Awards & Advancement

Neurotrope forms Clinical Advisory Board to support Alzheimer's disease program

Friday, January 16, 2015 10:43 AM

Neurotrope has formed its Alzheimer's Disease Clinical Advisory Board (CAB) with the following appointments: Jeffery L. Cummings, M.D., ScD, CCF; Martin R. Farlow, M.D.; Sam Gandy, M.D., Ph.D.; Christina Sampaio, M.D., Ph.D.; and Michael Weiner, M.D.

More... »


Astellas Pharma hires global executive Eric Terhaerdt

Friday, January 16, 2015 10:11 AM

Eric Terhaerdt has been named senior vice president of Global Development Operations for Astellas Pharma, based in Tokyo, Japan. Terhaerdt will be located at Astellas' headquarters for the Americas in Northbrook, Ill., and will report to Dr. Bernie Zeiher, executive vice president, Global Development and Therapeutic Area head: immunology, infectious disease, transplantation and central nervous system and pain, with Astellas Pharma Global Development.

More... »


American Diabetes Association announces new national officers and board members

Thursday, January 8, 2015 01:54 PM

The American Diabetes Association, a voluntary health organization leading the fight to Stop Diabetes, has announced its officers and board of directors members for 2015.

More... »

Carl Feldbaum joins Trovagene's board of directors

Thursday, January 8, 2015 01:17 PM

Trovagene, a developer of cell-free molecular diagnostics, has announced that Carl Feldbaum, president emeritus of the Biotechnology Industry Organization (BIO), a biotechnology trade association, has been appointed to its board of directors. He also will be chairman of the company's Corporate Governance and Nominating committee.

More... »

Heptares expands board of directors

Thursday, January 8, 2015 12:41 PM

Heptares Therapeutics, a clinical-stage GPCR structure-guided drug discovery and development company, has appointed Atul Pande and Roberto Solari to its board of directors. Pande and Solari bring significant industry experience in the discovery and validation of drug targets and the subsequent development of novel medicines.

More... »

Parexel ClinPhone RTSM named interactive response technology leader

Monday, December 15, 2014 12:48 PM

Parexel International, a global biopharmaceutical services provider, has announced that its randomization and trial supply management (RTSM) services, ClinPhone RTSM, ranked as the leader of Interactive Response Technology (IRT), according to a new global survey of pharmaceutical and biotechnology companies by Industry Standard Research (ISR). ClinPhone RTSM also was cited as the most preferred and widely used IRT solution.

More... »

NIH recruits three Lasker Clinical Research Scholars

Monday, December 15, 2014 12:19 PM

The NIH has selected three researchers as new Lasker Clinical Research Scholars as part of a joint initiative with the Albert and Mary Lasker Foundation to nurture the next generation of great clinical scientists.

More... »

CRF Health boosts leadership team with new appointments

Monday, December 15, 2014 08:00 AM

CRF Health, a Plymouth Meeting, Pa.-based global provider of eCOA solutions for the life sciences Industry, has announced two new additions to the company's executive leadership team as the organization continues to invest in a deeper and broader management structure to position the business for future growth.

More... »

EFPIA hires Joe Jimenez, CEO of Novartis, as new president

Thursday, December 11, 2014 12:06 PM

EFPIA has appointed Joe Jimenez, CEO of Novartis, as its new president. He will work alongside Dr. Stefan Oschmann, CEO Pharma of Merck, and Marc de Garidel, chairman and CEO of Ipsen, who have been appointed as vice presidents by the board.

More... »

CluePoints wins European Venture Contest award

Thursday, December 11, 2014 10:57 AM

CluePoints, a Cambridge, Mass.-based provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has won a European Venture Contest award. The award program, which is part of the European Venture Summit, acknowledged CluePoints for its Central Statistical Monitoring (CSM) solution that employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data. The win represents the second industry award that CluePoints has secured this month after the company's risk-based monitoring solution also was recognized by the Scrip Awards.

More... »

Subscribe to The CenterWatch Monthly
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs